Literature DB >> 21791591

Quality and reproducibility of retinal thickness measurements in two spectral-domain optical coherence tomography machines.

Ilse Krebs1, Eva Smretschnig, Sarah Moussa, Werner Brannath, Irene Womastek, Susanne Binder.   

Abstract

PURPOSE: To evaluate the accuracy and reproducibility of retinal thickness measurements in exudative age-related macular degeneration (AMD) by the Spectralis (Heidelberg Engineering, Heidelberg, Germany) and the Cirrus (Carl Zeiss Meditec, Dublin, CA) optical coherence tomography (OCT) systems.
METHODS: Eyes with exudative age-related macular degeneration were randomly assigned to one of eight groups, each different in the sequence of examiner and OCT system. The 512 × 128 cube program of the Cirrus and the 30° × 25° volume scan containing 32 lines of the Spectralis were performed twice. The correlation between the examinations was expressed by the interclass correlation coefficient (ICC).
RESULTS: Enrolled in the study were 112 patients and 112 eyes (mean age, 76.5 ± 7.9 years; range 51-89), with 14 patients in each group. The mean error scores per line were 0.53 and 0.52 in the Cirrus, significantly (P < 0.001) lower than in the Spectralis (0.83 and 0.98). For automatic central retinal thickness (CRT), the ICC for Cirrus (all examinations calculated) was 0.61 for groups 1 to 4 (the same examiner) and 0.65 for groups 5 to 8 (two different examiners); for Spectralis (13.4% not calculated) the ICC was 0.93 for groups 1 to 4 and 0.86 for groups 5 to 8. After error correction, the Cirrus ICC improved to 1.0 and 0.99 and the Spectralis ICC to 1.0 in both groups.
CONCLUSIONS: Considerable differences were found between the two systems, both of which incorporate the spectral-domain technology. Different positioning of segmentation lines, control of localization, density of included scan lines, and number of available maps explain the differences in segmentation quality and reproducibility. Manual correction of segmentation and centralization improves the reproducibility.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791591     DOI: 10.1167/iovs.10-6612

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

Review 1.  Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2014-08-01

2.  Effect of optical coherence tomography scan decentration on macular center subfield thickness measurements.

Authors:  Jeong W Pak; Ashwini Narkar; Sapna Gangaputra; Ronald Klein; Barbara Klein; Stacy Meuer; Yijun Huang; Ronald P Danis
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-02       Impact factor: 4.799

3.  Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems.

Authors:  Joo Yong Lee; Stephanie J Chiu; Pratul P Srinivasan; Joseph A Izatt; Cynthia A Toth; Sina Farsiu; Glenn J Jaffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

4.  The Photopic Negative Response in Idiopathic Intracranial Hypertension.

Authors:  Heather E Moss; Jason C Park; J Jason McAnany
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

5.  Electroretinography in idiopathic intracranial hypertension: comparison of the pattern ERG and the photopic negative response.

Authors:  Jason C Park; Heather E Moss; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2017-11-14       Impact factor: 2.379

6.  Early postoperative changes of the foveal surface in epiretinal membranes: comparison of 23-gauge macular surgery with air vs. balanced salt solution.

Authors:  Martin A Leitritz; Focke Ziemssen; Bogomil Voykov; Spyridon Dimopoulos; Ditta Zobor; Karl U Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-04       Impact factor: 3.117

Review 7.  Clinical application of ocular imaging.

Authors:  Zach Nadler; Gadi Wollstein; Hiroshi Ishikawa; Joel S Schuman
Journal:  Optom Vis Sci       Date:  2012-05       Impact factor: 1.973

8.  Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.

Authors:  Maria A Parker; Laura R Erker; Isabelle Audo; Dongseok Choi; Saddek Mohand-Said; Kastytis Sestakauskas; Patrick Benoit; Terence Appelqvist; Melissa Krahmer; Caroline Ségaut-Prévost; Brandon J Lujan; Ambar Faridi; Elvira N Chegarnov; Peter N Steinkamp; Cristy Ku; Mariana Matioli da Palma; Pierre-Olivier Barale; Sarah Ayelo-Scheer; Andreas Lauer; Tim Stout; David J Wilson; Richard G Weleber; Mark E Pennesi; José Alain Sahel; Paul Yang
Journal:  Am J Ophthalmol       Date:  2022-03-04       Impact factor: 5.488

9.  Reading Center Characterization of Central Retinal Vein Occlusion Using Optical Coherence Tomography During the COPERNICUS Trial.

Authors:  Francis Char Decroos; Sandra S Stinnett; Cynthia S Heydary; Russell E Burns; Glenn J Jaffe
Journal:  Transl Vis Sci Technol       Date:  2013-12-23       Impact factor: 3.283

10.  Validation of Optical Coherence Tomography Retinal Segmentation in Neurodegenerative Disease.

Authors:  Bryan M Wong; Richard W Cheng; Efrem D Mandelcorn; Edward Margolin; Sherif El-Defrawy; Peng Yan; Anna T Santiago; Elena Leontieva; Wendy Lou; Wendy Hatch; Christopher Hudson
Journal:  Transl Vis Sci Technol       Date:  2019-09-11       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.